WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticoagulant_Master_CMAP_v7, Time to the first occurrence of Non-CNS systemic embolism (SEE) has_components CRF: Non-CNS systemic embolism (SEE), Type of visit has_option Office, Time to the first occurrence of stroke has_component CRF: Stroke, Safety endpoint has_component CRF: Adverse event (AE)s, Study visit has_component Date of visit, Safety endpoint has_component Hepatotoxicity, Primary efficacy endpoints has_components Time to the first occurrence of Non-CNS systemic embolism (SEE), FDA Endpoints for Anticoagulant Therapy refers_to Safety endpoint, Repeated concepts/instances (e.g. Stroke, Death) are denoted by dotted outline, Study visit has_component Type of visit, Secondary efficacy endpoint has_compnents Individual secondary endpoints, Hospitalization indicates Severity of bleed, Safety endpoint has_component Incidence of bleeding events, Incidence of bleeding events has_component Bleeding events, CRF: Non-CNS systemic embolism (SEE) is_documented_at Study visit, CRF: Non-CNS systemic embolism (SEE) occurs_during Timepoints, Concepts which may be removed (for simplicity) are denoted by Gray shading, Type of visit has_option Phone call, Instances of concepts are denoted by Solid square-edged rectangle, Type of visit has_option Other